Chard Daniel R's Form 4 filing
Medifast Inc (MED) · filed Mar 27, 2026
- Accession no.
- 0001628280-26-021795
- Filed
- Mar 27, 2026
- Trade date
- Mar 13-25, 2026
- Filing delay
- 14 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market purchases total $178.7K. It was filed 14 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chard Daniel RCIK 0001289557 | Director, Officer (Chairman & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | Common Stock | FTax withholdingDisposed | −7,075 | $9.62 | −$68,061.5 | 169,171 | Direct | |
| Mar 17, 2026 | Common Stock | FTax withholdingDisposed | −2,638 | $10.05 | −$26,511.9 | 166,533 | Direct | |
| Mar 20, 2026 | Common Stock | PPurchaseAcquired | +17,678 | $10.11 | +$178,724.58 | 17,678 | Indirect | |
| Mar 25, 2026 | Common Stock | FTax withholdingDisposed | −20,095 | $9.59 | −$192,711.05 | 146,438 | Direct | |
| Mar 25, 2026 | Common Stock | AGrant or awardAcquired | +36,968 | $0.00 | $0 | 183,406 | Direct | |
| Mar 25, 2026 | Common Stock | AGrant or awardAcquired | +4,827 | $0.00 | $0 | 188,233 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.